| Dr Bindu Jayavelu, MD | |
|
301 S Power Rd Ste 103, Mesa, AZ 85206-5243 | |
| (480) 325-7535 | |
| (480) 325-7462 |
| Full Name | Dr Bindu Jayavelu |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 27 Years |
| Location | 301 S Power Rd Ste 103, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003965278 | NPI | - | NPPES |
| 234662 | Medicaid | AZ | |
| Z148451 | Other | AZ | BANNER MD ANDERSON CANCER CENTER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 36505 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Power Road Dialysis (dva) | Mesa, AZ | Dialysis facility |
| Southwest Kidney Dialysis - Gilbert (dva) | Gilbert, AZ | Dialysis facility |
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Banner Ironwood Medical Center | Queen creek, AZ | Hospital |
| Dignity Health Arizona General Hospital | Mesa, AZ | Hospital |
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Banner Casa Grande Medical Center | Casa grande, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Cancer Center Specialists Llc | 6103097779 | 266 |
| Southwest Kidney Institute Plc | 8224930987 | 81 |
News Archive
Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).
Researchers have made an important discovery that may explain how gut bacteria could contribute to autism-like behaviors.
A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.
Reporting for Kaiser Health News, in collaboration with The New York Times, Susan Okie writes: "Doctors in training have traditionally been insulated from information about the cost of the tests and treatments they order for patients — in fact, for decades, the subject was virtually taboo when professors and trainees discussed treatment decisions during hospital rounds.
› Verified 4 days ago
| Entity Name | Southwest Kidney Institute Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659316008 PECOS PAC ID: 8224930987 Enrollment ID: O20040211001069 |
News Archive
Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).
Researchers have made an important discovery that may explain how gut bacteria could contribute to autism-like behaviors.
A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.
Reporting for Kaiser Health News, in collaboration with The New York Times, Susan Okie writes: "Doctors in training have traditionally been insulated from information about the cost of the tests and treatments they order for patients — in fact, for decades, the subject was virtually taboo when professors and trainees discussed treatment decisions during hospital rounds.
› Verified 4 days ago
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).
Researchers have made an important discovery that may explain how gut bacteria could contribute to autism-like behaviors.
A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.
Reporting for Kaiser Health News, in collaboration with The New York Times, Susan Okie writes: "Doctors in training have traditionally been insulated from information about the cost of the tests and treatments they order for patients — in fact, for decades, the subject was virtually taboo when professors and trainees discussed treatment decisions during hospital rounds.
› Verified 4 days ago
| Entity Name | Southwest Kidney Institute Scottsdale Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902231012 PECOS PAC ID: 3577798313 Enrollment ID: O20131101000457 |
News Archive
Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).
Researchers have made an important discovery that may explain how gut bacteria could contribute to autism-like behaviors.
A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.
Reporting for Kaiser Health News, in collaboration with The New York Times, Susan Okie writes: "Doctors in training have traditionally been insulated from information about the cost of the tests and treatments they order for patients — in fact, for decades, the subject was virtually taboo when professors and trainees discussed treatment decisions during hospital rounds.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bindu Jayavelu, MD 2149 E Warner Rd, Suite 101, Tempe, AZ 85284-3494 Ph: (480) 610-6100 | Dr Bindu Jayavelu, MD 301 S Power Rd Ste 103, Mesa, AZ 85206-5243 Ph: (480) 325-7535 |
News Archive
Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).
Researchers have made an important discovery that may explain how gut bacteria could contribute to autism-like behaviors.
A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.
Reporting for Kaiser Health News, in collaboration with The New York Times, Susan Okie writes: "Doctors in training have traditionally been insulated from information about the cost of the tests and treatments they order for patients — in fact, for decades, the subject was virtually taboo when professors and trainees discussed treatment decisions during hospital rounds.
› Verified 4 days ago
Dr. Emmanuel A Bayongan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Mr. Robert Bobek Arashahi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5652 E Baseline Rd, Mesa, AZ 85206 Phone: 480-477-7166 | |
Mr. Robert P Tully, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |